4 D Molecular Therapeutics Inc (FDMT)

Finanzdaten der 4 D Molecular Therapeutics Inc-Aktie (FDMT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	24.09%3.78	3.05	85.09	0.09	0.02
Operating Expenses	5.40%80.81	76.67	70.38	61.28	59.47
Depreciation and Amortization	0.87%1.28	1.27	1.22	1.26	1.17
Operating Income/Loss	4.63%-77.03	-73.62	14.72	-61.19	-59.46
Nonoperating Income/Loss	15.86%4.09	4.86	4.68	4.31	4.80
Income Tax Expense/Benefit	-	-	-	-	-
	6.07%-72.94	-68.76	19.40	-56.88	-54.66
Attributable To Parent	6.07%-72.94	-68.76	19.40	-56.88	-54.66
Available To Common Stockholders, Basic	6.07%-72.94	-68.76	19.40	-56.88	-54.66
Basic Average Shares	3.24%70.27	68.06	-	56.13	55.93
Diluted Average Shares	3.24%70.27	68.06	-	56.13	55.93
Basic Earnings Per Share	2.97%-1.04	-1.01	-	-1.01	-0.98
Diluted Earnings Per Share	2.97%-1.04	-1.01	-	-1.01	-0.98